Vyteris announces first successful noninvasive delivery of peptide using smart patch technology. The registered agent on file for this company is csc services of nevada, inc. The following is a summary of the information contained in this traditional 5 10k application. Lidosite is the first active transdermal patch approved by the u. Vytr, developer of the first fdaapproved active transdermal drug delivery system and a leader in active transdermal drug delivery technology, announced an agreement with zealand pharma as, a denmarkbased biopharmaceutical company dedicated to the discovery and development of innovative peptide. Fair lawn areas dirty little secrets fair lawn, nj patch. To get access to the full report and learn more about creditriskmonitors robust financial risk analysis and timely news service, request a personalized demo and free trial today.
Fair lawn saddle brook, nj news local weather forecast for the weekend ahead fair lawn saddle brook, nj news walmart begins implementing oneway. Rafael espinal, former vice presidentmanufacturing at. Jul, 2010 fair lawn, nj marketwire july, 2010 vyteris, inc. Vytr, developer of the first fdaapproved active transdermal drug delivery system and a leader in active transdermal drug delivery technology, announced an agreement with zealand pharma as, a denmarkbased biopharmaceutical company dedicated to the discovery and development of innovative peptidebased drugs, to apply vyteris technology to the controlled transdermal. It was formerly known as vyteris holdings nevada, inc. Vytr, manufacturer of the first fdaapproved active transdermal drug delivery system and a leader in active transdermal drug delivery technology, has announced the initiation of a phase ii clinical trial sponsored by its development partner, ferring pharmaceuticals, inc.
Find people and find the right business and get things done. The trial evaluates vyteris smart patch technology for the. Unlike other intelligence solutions, bciq exclusively supports the unique needs of the biopharma industry and. Vyteris inc at 1 pollitt dr ste 1, fair lawn, nj 07410. The last role of solomon mikhoels presented in russian by. Vytr, manufacturer of the first fdaapproved active transdermal drug delivery system and a leader in active transdermal drug.
Hyperlocal news, alerts, discussions and events for fair lawn saddle brook, nj. As expected and predicted, the cases have increased significantly in the last week with more people being tested. Fair lawn, nj, apr 14, 2009 market wire via comtex news network vyteris, inc. Municipal clerks office room 206, housing liaison office room 209 and health and human services room 109 fair lawn public library fair lawn senior center.
Fair lawn, nj, sep, 2010 marketwire via comtex news network vyteris, inc. The lidosite topical system lidosite system consists of a lidosite patch and a lidosite controller, a portable microprocessorcontrolled batterypowered dc current source. Address of location of vyteris s facility in fair lawn, new jersey, including county and name and address of landlord or owner if location is not owned by vyteris. Vyteris to present at lazard capital markets 7th annual. Baskinger associate director, regulatory affairs dear mr. The objective was to evaluate the transdermal delivery of the 5ht1b1d agonist, sumatriptan from an iontophoretic patch system, in vivo. Vyteris initiates phase ii clinical trial of infertility. In vitro and in vivo evaluation of the transdermal iontophoretic. Lidosite patches should not be reapplied to a skin site that has previously been treated with a lidosite patch. Vyteris announces positive results from phase ii clinical.
The film backing protects the polymeric phase of the matrix patch and prevents. Federal register pan american laboratories, llc, et al. Vytr, manufacturer of the first fdaapproved active patch transdermal drug delivery system, and a leader in active transdermal drug delivery technology, today announced the appointment of four new members to its scientific advisory board sab. Vyteris proprietary active transdermal smart patch technology delivers drugs comfortably through the skin using lowlevel electrical energy iontophoresis. The patch is placeable against the skin 10 of a patient so that the anode electrode 6 and cathode electrode 8 are in electrical communication with the patients skin. Nj coronavirus deaths decline for 4th straight day. Fair lawn, nj and bethlehem, pa october 8, 2002 vyteris, inc.
Food and drug administration fda approved electronic transdermal patches include lidosite vyteris inc. Vytr, developer of the first fdaapproved active transdermal patch and a leader in alternative drug delivery technology, today announced positive results from a phase ii clinical trial evaluating the safety and efficacy of a pulsatile delivery system for the. New phase iv clinical study indicates lidosite provides. All individuals from fair lawn are hospitalized, selfquarantined or selfisolated at this time. Fair lawn is a borough in bergen county, new jersey, united states, and a suburb located 10 miles 16 km from new york city. Vytr, manufacturer of the first fdaapproved active transdermal drug delivery system and a leader in active transdermal drug delivery technology, has announced the initiation of a phase ii clinical trial sponsored by its development partner, ferring pharmaceuticals inc. Vyteris and zealand pharma announce agreement on active. Jun 11, 2002 the transdermal patch basically includes a first electrode 6, which may act as an anode, and a second electrode 8, which may act as a cathode. The borough would like to honor our military and veteran. Nearby schools include warren point elementary school, thomas jefferson middle school and fair lawn high. Rafael espinal is former vice presidentmanufacturing at vyteris, inc. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate. Apr 16, 20 lidocaine combined with epinephrine was approved by the fda as a local anaesthetic in 2004 lidosite. New localized pain treatment system available from b.
For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, bciq provides accurate information and context to support profitable and strategic decision making. Vyteris closes merger with medisync bioservices business. Vyteris is the maker of the first active drug delivery patch to receive market approval from the u. The prefilled disposable patch was clinically tested in both adults and children and found to significantly decrease pain from needle injections and similar procedures in both groups. Vyteris has a license and development agreement with ferring pharmaceuticals, inc. Fair lawn company is transforming drug delivery vyteris, coming off a merger sept. Sample agreements, legal documents, and contracts from realdealdocs. Vyteris is a pharmaceutical company manufacturing products that deliver drugs through the skin. Fair lawn, new jersey nj income map, earnings map, and. Vyteris is the maker of the first active drug delivery patch to receive market approval from the. Vytr today announced that on april 6, 2011, the company closed on its previously announced agreement to. Terms of service privacy policy sitemap 2020 crunchbase inc.
All other trademarks, servicemarks or trade names referred to in this quarterly report on form 10q are the property of their respective owners. To find items related to boards, commissions and committees, please check our notices page. Vyteris announces first successful noninvasive delivery. Fda finds that the holders of the ndas listed in table 1 have repeatedly failed to submit reports required by 314. Vyteris inc company profile and news bloomberg markets. Aug 11, 2010 vyteris announces positive results from phase ii clinical trial of transdermal patch for female infertility fair lawn, nj, aug 10, 2010 marketwire via comtex vyteris, inc. Lidosite fda prescribing information, side effects and uses. Vytr, developer of the first fdaapproved active transdermal drug delivery system and a leader in active transdermal drug delivery technology, announced an agreement with zealand pharma as, a denmarkbased biopharmaceutical company dedicated to the discovery and development of innovative peptidebased drugs, to apply vyteris technology to the controlled. Braun to market vyteris \ transdermal lidocaine system which is being developed to provide fast and effective dermal anesthesia for use before such invasive procedures as venipunctures, bloodraws. Company profile page for vyteris inc including stock price, company news, press releases, executives, board members, and contact information. Fair lawn, nj marking an advance in the widespread distribution of rapid. Feb 18, 2003 the patch includes an anode and cathode electrode iontophoretic drug delivery device having highefficiency dctodc energy conversion circuit vyteris, inc.
Fair lawnsaddle brook, nj news local weather forecast for the weekend ahead fair lawnsaddle brook, nj news walmart begins implementing oneway aisles teaneck, nj news coronavirus claims lives of. Where indicated by yes, creditriskmonitor contains this information in its extensive database. Apr 23, 2014 vyteris has a license and development agreement with ferring pharmaceuticals, inc. The structure of the skin is altered at the submicroscopic scale,but the effects are reversible. We believe a business or home with clean air and no mold will not only help you and your family, employees, and clients but your pets too. Address of location of vyteriss facility in fair lawn, new jersey, including county and name and address of landlord or owner if location is not owned by vyteris. Vyhn, today announced results from a new phase iv open label clinical study demonstrating that lidosite, the first fda approved active patch for dermal analgesia, provided better pain relief to more than 73 percent of patients receiving injections of hyaluronic acid during treatment for osteoarthritis. Cherichella as chief financial officer and principal accounting officer, overseeing. Vytr, developer of the first fdaapproved active transdermal patch and a leader in alternative drug delivery technology, today announced positive results from a phase ii clinical trial evaluating the safety and efficacy of a pulsatile delivery system for the treatment of female infertility, based on the companys smart patch. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the u. Lidosite patch lidocaine hcl and epinephrine topical iontophoretic patch 10%0. Fair lawn, nj patch fair lawnsaddle brook, nj patch. Baskinger manager, quality management and regulatory compliance 5. Fair lawn saddle brook, nj local and regional health news, fitness tips and wellness information.
Vytr, developer of the first fdaapproved active transdermal patch and an innovator in alternative drug delivery technology, today announced that it has executed a definitive merger agreement with medisync bioservices inc. The company is headquartered in fair lawn, new jersey. Vyteris received regulatory approval from the food and drug administration in may 2004 and expects to be the first company to market a userfriendly, prefilled, preprogrammed iontophoretic system. Announces lidosite marketing agreement with labcorp. Vyteris first product, lidosite, which provides dermal analgesia prior to venipuncture iv catheter insertions, blood draws, etc. Fair lawn saddle brook, nj news local weather forecast for the weekend ahead fair lawn saddle brook, nj news walmart begins implementing oneway aisles teaneck, nj news coronavirus claims lives of. Iontophoretic drug delivery device having highefficiency dc. Vyteris announces positive results from phase ii clinical trial of transdermal patch for female infertility fair lawn, nj, aug 10, 2010 marketwire via comtex vyteris, inc. Four drugs using transdermal patches for the management of central nervous. Combination with epinephrine aims at decreasing skin blood flow, thus reducing skin clearance of the drug and consequently increasing the dermal concentration 40 and prolonging the anaesthetic action of. Aug 14, 2007 fair lawn, nj marking an advance in the widespread distribution of rapid pain relief from procedures involving venipuncture, intravenous cannulation and laser ablation of superficial skin lesions, vyteris, inc. Braun is the exclusive marketing partner of vyteris for the lidosite topical system. Vyteris was organized in november 2000 as a spinout of the transdermal systems unit of becton dickinson and company bd, to develop, manufacture, and commercialize. Vytr, manufacturer of the first fdaapproved active patch transdermal drug delivery system and a leader in active transdermal drug delivery technology, today announced that president and chief executive officer haro hartounian, ph.
This page provides available department news and announcements. The companys filing status is listed as revoked and its file number is c51751997. Fair lawn, nj, aug 10, 2010 marketwire via comtex vyteris, inc. Promptly following the execution and delivery of this letter agreement, vyteris and ferring shall agree upon a final 2009 patch development budget. Vyteris announces definitive agreement to merge with. Fair lawn company is transforming drug delivery patch. The first transdermal system for systemic deliverya threeday patch that delivered scopolamine to treat. Us8629184b2 topical formulations for treatment of neuropathy. The lidosite system delivers lidocaine and epinephrine simultaneously by topical iontophoresis to achieve dermal analgesia on intact skin.
The companys address is 1 pollitt drive, fair lawn, new jersey 07410, and its telephone number is 201 7032299. Business wiremar 19, 2007 vyteris holdings nevada, inc. Fair lawn, njmarketwire april 14, 2009 vyteris, inc. Fair lawn, nj patch breaking local news events schools weather. Hyperlocal news, alerts, discussions and events for fair lawnsaddle brook, nj.
Fair lawn, njmarketwire march 10, 2009 vyteris, inc. Fair lawn currently has 365 positive cases of the covid19 virus. Aug 22, 2019 a second application using a new lidosite patch may be applied after 30 minutes to a different skin site. Fair lawn, njmarketwire september 07, 2010 vyteris, inc. Search or browse our list of companies in fair lawn, new jersey by category. Find 81 listings related to vyteris inc in fair lawn on. View 1 photos for 215 27th st, fair lawn, nj 07410 a bed, bath. Vytr, developer of the first fdaapproved active transdermal drug delivery system and a leader in active transdermal drug. Innovative drug delivery technologies are playing an increasingly important role in extending lifecycles, differentiating metoo products and unlocking the value of new compounds with challenging delivery requirements, writes steven seget in a report from scrip insights. Fair lawn, nj marketwire august 10, 2010 vyteris, inc.
717 595 1074 927 982 81 119 733 23 761 756 1032 1508 260 365 700 1424 1145 111 827 486 356 526 325 649 626 634 459 113 755 186 330 1419 1028 1022 1422 425 689 771